In heterozygotes for multiple sulfatase deficiency (MSD), several sulfatase activities including arylsulfatases A, BI, B2, and C, and cholesterol sulfatase were 40-50% of normals in cultured skin fibroblasts and 70-80% of normals in leukocytes. In MSD patients, these enzyme activities were deficient or reduced. DEAE-Sepharose column chromatographic patterns of 4-methylumbelliferyl sulfatases A, B1, and B2 in leukocytes and cultured skin fibroblasts from MSD patients and heterozygotes were also consistent with the above data. These data indicate that several sulfatase activities in heterozygotes of MSD exhibited intermediate activities as observed in the heterozygote state of other autosomal recessive inherited diseases.
MSD, and a MSD obligate heterozygote (mother). Three different cell cultures of MSD proband were kindly obtained from Prof. H. Kihara (University of California, Pomona USA). Two MSD probands (GM 3245 and GM 2407) and two MSD heterozygote cell cultures (GM 2644 and GM 2667) were shipped from the Human Genetic Cell Repository, Camden, NJ. The cultures were grown under conditions described previously (7) . The leukocyte or fibroblast cells were suspended in 0.05 M Tris-HC1 buffer, pH 7.4 and dialyzed overnight against 0.02 M Tris-HC1 buffer (pH 7.4). The cells were disrupted by sonication for 60 sec at 40 "K" cycles in a Branson sonifier. The homogenates were used for enzyme assays of arylsulfatase C, cholesterol sulfatase, and heparin N-sulfatase. For the determination of other sulfatases (arylsulfatases A and B), the homogenate was centrifuged at 100,000 x g for 30 min and the clear supernatant was used for enzyme assays.
Abbreviations
For the fractionation with DEAE-Sepharose column chromatog-MDS, multiple sulfatase deficiency raphy, the soluble fraction was used.
MLD, metachromatic leukodystrophy 4-MU, 4-methylumbelliferyl
Multiple sulfatase deficiency (MSD) is an autosomal recessive disorder, which is clinically characterized by gargoyl-like appearance, skeletal abnormality, hepatosplenomegaly, and ichthyosis (1, 2). Biochemically, the accumulation of sulfatide, acid mucopolysaccharides, and cholesterol sulfate accompanies deficiencies 300 of arylsulfatases A, B, and C , mucopolysaccharide sulfatases -200 (sulfoiduronate sulfatase, sulfamidase, galactosamine-4-sulfatase, galactosamine-6-sulfatase) and steroid sulfatases (cholesterol sulloo fatase, dehydroepiandrosterone sulfatase, estrone sulfatase, pregnenolone sulfatase) in patients' tissues and cultured skin fibroblasts (1, 2,.3, 7, 18) .
This disorder is of considerable theoretical interest in genetics, because there are deficient activities of several different enzymes. In terms of the genetic controlling mechanisms of sulfatases, it is important to determine whether sulfatase activities in the heterozygote exhibit intermediate activities.
This report demonstrates that various sulfatase activities in heterozygotes were about one-half of controls in cultured skin fibroblasts and 70-80% of controls in leukocytes. In addition, the arylsulfatase characteristics in MSD patients were indistinguishable from those in normals. The clinical and biochemical findings of a Japanese case of patients with metachromatic leukodystrophy (MLD), multiple sulfase MSD were reported previously (9) . Enzyme assay. Arylsulfatase A activity was determined using p- acetate buffer (pH 6.0) and studied for Km, thermostability, optimal pH and effects of ions.
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RESULTS
Various sulfatase activities in cultured skin fibroblasts (Fig. 1) . and 54% in heterozygotes for MSD, respectively. Heparin Nsulfatase was 0.5% in MSD patients.
Various sulfatase activities including arylsulfatases
Various sulfatase activities in leukocytes (Fig. 2) . Arylsulfatase A activity in leukocytes from MSD patients and obligate heterozygotes were 5% and 60% less than that of controls, respectively. Arylsulfatases B1 and B2 activities were practically absent in MSD patients and 70% in its heterozygotes. Arylsulfatase C activity was deficient in MSD patients and 59% in heterozygotes. A sister of the Japanese case of MSD showed arylsulfatases A, B 1, and B2, and C activities within normal ranges. Figures 3 and  4 show the column chromatographic patterns of 4-MU and pnitrocatechol arylsulfatases from cultured skin fibroblasts and leukocytes of patients with MLD, MSD, and their heterozygotes. In control fibroblasts, 4-MU arylsulfatase activities were fractionated into three major fractions, designated as A, B I, and B2. The fraction B2 is considered to be a minor arylsulfatase B reported by Fluharty et a/.
DEAE-sepharose column chromatography of 4-MU arylsulfatases from leukocytes and cultured skin fibroblasts.
(1 1).
The MSD patient showed a deficiency of each component of the 4-MU arylsulfatases as well as ofp-nitrocatechol arylsulfatase. In the heterozygote, each component of arylsulfatase activity was reduced to roughly one-half the control, as shown in Figure 3 . The MSD patient and heterozygote did not show different elution patterns of arylsulfatases, as compared with those of controls. Using p-nitrocatechol sulfate as a substrate, these patterns were essentially similar to those of control. Arylsulfatases A, B1, and B2 activities in the MSD patient's leukocytes were practically absent.
Enzyme characteristics of 4-MU arylsulfatases A, BI, and B2.
Km values of arylsulfatases A, B1, and B2 in control leukocytes were 0.2, 0.1, and 0.5 x lo4 M, respectively. In the MSD heterozygote these are 0.2, 0.3, and 0.3 X lo4 M, respectively. Optimal pHs of arylsulfatases A, B1, and B2 in control leukocytes were 5.6, 5.2 and 5.2, respectively. The MSD heterozygote showed a similar optimal pH to those of control. Effects of ions by Ba++, Mg++, Ca+*, Ag", and Hg" in MSD heterozygote were essentially similar to those of control (the data is not shown). Results obtained from cultured skin fibroblasts were similar to those obtained from leukocytes for both the MSD patient and its heterozygotes.
DISCUSSION
Several sulfatase activities including arylsulfatases A, Bl, B2, C, cholesterol sulfatase and heparin N-sulfatase were deficient or reduced in activity in cultured skin fibroblasts and leukocytes from patients with MSD. Deficient activities of several sulfatases in cultured skin fibroblasts with MSD have been described previously (3, 7), whereas these enzyme activities in leukocytes from MSD patients have been described. Several sulfatase activities in MSD leukocytes were practically absent, as compared with those from MSD cultured skin fibroblasts in which significant amounts of residual activities were present. This difference might be due to culture conditions, because Fluharty et a/. (12, 13) reported that alkaline pH in the culture medium induced arylsulfatase A in MSD fibroblasts and also fetal calf serum contained predominantly arylsulfatase B rather than arylsulfatase A (unpublished observation).
Several sulfatase activities in heterozygotes with MSD have not been reported previously. As shown in Figures 1 and 2 , several sulfatase activities in cultured skin fibroblasts were almost onehalf of controls in three heterozygotes of MSD patients, whereas these enzyme activities in leukocytes from MSD heterozygotes overla~ved with control individuals. These differences might be 1 1 " due to heterogeneous populations in leukocytes as compared with those of cultured skin fibroblasts. It is therefore advisable to detect heterozygotes in cultured skin fibroblasts. The reduced activities of arylsulfatases A, B1, B2, and C in leukocytes and cultured skin fibroblasts were confirmed by the experiments with DEAE-Sepharose column chromatography. The presence of an abnormal peak with 4-MU sulfatases was not observed in either leukocytes or cultured skin fibroblasts preparations. Enzyme kinetics and characteristics of isolated 4-MU sulfatases in leukocytes and cultured skin fibroblasts from the heterozygote and the patient with MSD suggest that the reduced activities of the various sulfatases are due to quantitatively reduced normal enzymes, indistinguishable from the enzymes in normal controls. These findings also confirmed the results of Fiddler et al. (10) who showed that arylsulfatases A and B in this disorder are reduced in their levels of cross reacting materials against antiarylsulfatases A and B antibodies.
Reduced activities of various sulfatases in MSD heterozygotes may support the hypothesis that the multiple sulfatase defic&cies in this disorder are ~robablv due to a single mutation of a sulfatase gene controlling sy'stem. ~i e previous cypotheses such as a mutation in a subunit, cofactor, or inhibitor common to these sulfatases can be ruled out by immunologic studies reported by Fiddler et al. (10) . Of interest is that affected enzymes in this disorder are produced by both autosomal and X-linked chromosomes. Arylsulfatases A and B and heparin N-sulfatase are known to be localized in autosomal genes (arylsulfatase A in chromosome number 22 (6) and B in chromosome number 5) (6), whereas arylsulfatase C, cholesterol sulfatase, other steroid sulfatase and sulfoiduronate sulfatase are considered to be localized in X-chromosomes (steroid sulfatase in Xg locus) (17) . Most recently, cell fusion studies in which MSD cells were fused with other sulfatase deficient disorder such as MLD, Maroteaux-Lamy syndrome, Sanfilippo A, steroid sulfatase deficient disorder and Hunter syndrome support the hypothesis than an enzyme deficiency in MSD is different from that causing specific sulfatase deficiencies (5, 14) . Intermediate activities of various sulfatases in MSD heterozygotes suggest that a defect of post-translational process, like I-cell disease, is not likely because the heterozygotes of I-cell disease did not show the intermediate activities of various lysosoma1 enzymes (15) . The occurrence of these different enzyme deficiencies in MSD patients suggests that there might be a defect in a gene controlling various sulfatase activities.
